Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 1.190
-0.010 (-0.83%)
Sep 21, 2026, 10:52 AM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 436.04 million as of September 18, 2026. Its market cap has decreased by -86.77% in one year.
Market Cap
436.04M
Enterprise Value
30.02M
Revenue
383.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.19
ChartMarket Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 436.04M, a decrease of -93.47%. That is a compound annual growth rate of -56.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 436.04M | -73.57% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 898.73M |
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 639.70M |
| Brii Biosciences | 638.80M |
| 3D Medicines | 607.42M |
| B&K Corporation | 470.63M |
| Uni-Bio Science Group | 435.90M |
| Transcenta Holding | 415.98M |